Suzanne Garner, a stage 2 breast cancer survivor, learned about the NATALEE trial via Outcomes4Me, an AI-driven platform integrated with the National Comprehensive Cancer Network’s Clinical Practice Guidelines in Oncology.
Outcomes4Me Announces Investments from Labcorp and Comcast’s Forecast Labs Learn more >>
